Document is current

Any future updates will be listed below

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

Crossref DOI link: https://doi.org/10.1007/s00520-014-2550-3

Published Online: 2014-12-10

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark